In a hospital cardiology setting, which beta-blocker is most appropriate to recommend for a patient with heart failure and reduced ejection fraction?

• A. Carvedilol
• B. Propranolol
• C. Metoprolol succinate
• D. Bisoprolol

Answer: (A)

In heart failure with reduced ejection fraction, blocking the harmful effects of chronic sympathetic stimulation improves survival and reduces hospitalizations. Carvedilol stands out because it blocks both beta receptors and alpha-1 receptors, giving not only rate and contractility control but also vasodilation with afterload reduction. This vasodilatory effect helps lower the pressure the failing heart must push against, which can translate into better forward flow and symptom relief while contributing to favorable outcomes shown in major trials. While other beta-blockers like metoprolol succinate and bisoprolol also reduce mortality in HFrEF, carvedilol’s added vasodilation makes it especially advantageous in a hospital cardiology setting, including in patients with higher afterload or hypertension. Propranolol lacks the targeted mortality benefit in HFrEF and isn’t preferred for this indication. Start at a low dose and titrate carefully while monitoring for bradycardia and hypotension.